![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 8, 5699-5702, February 22, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§ and
¶
From the
Center for Learning and Memory, RIKEN-MIT
Neuroscience Research Center, Departments of Brain and Cognitive
Sciences and Biology, Howard Hughes Medical Institute, Massachusetts
Institute of Technology, Cambridge, Massachusetts 02139 and the
§ Department of Neurology, Massachusetts General Hospital,
Boston, Massachusetts 02114
PDZ
domains1 are modular protein
interaction domains that play a role in protein targeting and protein
complex assembly. Once termed Discs-large homology regions (DHRs) or
GLGF repeats (after a conserved Gly-Leu-Gly-Phe sequence found within
the domain), these domains of ~90 amino acids are now primarily known
by an acronym of the first three PDZ-containing proteins identified: the postsynaptic protein PSD-95/SAP90, the
Drosophila septate junction protein Discs-large,
and the tight junction protein ZO-1. Since their initial
identification, PDZ and PDZ-like domains have been recognized in
numerous proteins from organisms as diverse as bacteria, plants, yeast,
metazoans, and Drosophila (1). In fact, they are among the
commonest protein domains represented in sequenced genomes. Analysis of
the human, Drosophila, and Caenorhabditis elegans
genomes estimates the presence of 440 PDZ domains in 259 different
proteins, 133 PDZ domains in 86 proteins, and 138 PDZ domains in 96 proteins, respectively (2).
The structural features of PDZ domains allow them to mediate specific
protein-protein interactions that underlie the assembly of large
protein complexes involved in signaling or subcellular transport. Not
surprisingly, disrupting these interactions can play a role in human
diseases. Mutations in a gene encoding harmonin, a PDZ-containing
protein, cause Usher syndrome type 1C, an autosomal recessive disorder
characterized by congenital sensorineural deafness, vestibular
dysfunction, and blindness (3-5). This was the first mutation in a
PDZ-encoding gene linked to a human disease. Subsequently, mutations in
the periaxin gene, which also encodes a PDZ-containing protein, have
been identified as a cause of Dejerine-Sottas neuropathy, a severe
demyelinating form of peripheral neuropathy (6, 7).
The notion that PDZ domains serve as protein interaction modules
emerged from the finding that the first and second PDZ (PDZ1 and -2)
domains of PSD-95 can bind the extreme C-terminal peptide sequence of
Shaker-type K+ channels (8) and NMDA receptor NR2 subunits
(9, 10). PDZ3 of the protein tyrosine phosphatase FAP-1/PTP1E similarly was identified as a binding site for the C terminus of the cell surface
receptor Fas (11). These studies further demonstrated that PDZ domains
maintained their activity and selectivity when expressed in
heterologous proteins, establishing these motifs as modular domains
that bind the C termini of target proteins in a sequence-specific manner.
The structural basis for PDZ specificity became apparent with the
solution of the x-ray crystallographic structure of PDZ domains
complexed with their cognate peptide ligands. First solved for PDZ3 of
PSD-95 (12, 13), numerous additional PDZ crystal structures have been
determined in recent years, including PDZ2 of PSD-95 (14), the single
PDZ domain of CASK (15), syntrophin (16) and neuronal nitric-oxide
synthase (nNOS) (17), PDZ2 from human phosphatase hPTP1E (18), PDZ1 of
the Na+/H+ exchanger regulatory factor (NHERF)
(19), and PDZ1 of InaD (20). The common structure of PDZ domains
comprises six
![]()
INTRODUCTION
TOP
INTRODUCTION
The Structural Basis of...
Regulation of PDZ Binding...
Binding of PDZ Domains...
Structural Features of PDZ-...
PDZ Domains as Organizers...
Conclusions
REFERENCES
![]()
The Structural Basis of PDZ Binding and Specificity
TOP
INTRODUCTION
The Structural Basis of...
Regulation of PDZ Binding...
Binding of PDZ Domains...
Structural Features of PDZ-...
PDZ Domains as Organizers...
Conclusions
REFERENCES
strands (
A-
F) and two
helices (
A and
B), which fold in an overall six-stranded
sandwich (Fig.
1A). C-terminal peptides bind
as an antiparallel
-strand in a groove between the
B strand and the
B helix, in essence extending one of the
-sheets. The
conserved Gly-Leu-Gly-Phe (GLGF) sequence of the PDZ domain is found
within the
A-
B connecting loop and is important for hydrogen
bond coordination of the C-terminal carboxylate (COO
)
group. The N and C termini of the PDZ domain are located near each
other on the opposite side of the PDZ domain from the peptide-binding site, a feature shared with other protein interaction modules such as
SH2 domains.

View larger version (15K):
[in a new window]
Fig. 1.
Structure of PDZ and PDZ-like domains.
A, ribbon diagram of PDZ3 of PSD-95 complexed with a
C-terminal peptide from CRIPT (12). The structure demonstrates the six
-strands (turquoise) and two
-helices (red)
with the peptide (yellow) binding as a
-strand between
the
B helix and
B strand. The N and C termini are labeled.
B, structure of
1-syntrophin PDZ domain complexed to nNOS
(green) (17). Note the overall similarity in PDZ structure
with replacement of the C-terminal peptide ligand by a
-finger.
C, ribbon diagram of the photosystem II D1 protease PDZ-like
domain from Scenedesmus obliquus (21). Although the overall
topology is similar to conventional PDZ domains, the
A strand is
derived from the C terminus of the domain.
PDZ-like domains identified in plants and bacteria have a similar
overall secondary and tertiary structure but show a different topology
(Fig. 1C). Specifically, the
A strand, derived from the
N-terminal sequences in conventional PDZ domains, is formed by the C
terminus in the PDZ-like domain of the photosystem II D1 C-terminal
protease (21). This circularly permuted fold, also found in the Tsp
protease from Escherichia coli, retains the ability to bind
C-terminal sequences (22).
The crystallographic data indicate that the C-terminal four residues of
PDZ ligands interact directly with the peptide-binding groove. The main
chain atoms of the
B strand form hydrogen bonds with the extended
peptide ligand and stabilize the interaction although they do not
account for sequence specificity. The specific interaction of
C-terminal sequences suggests that recognition of the carboxylate group
is critical for PDZ binding. Indeed, a highly conserved positively
charged residue (e.g. arginine 318 of PDZ3 of PSD-95) and
the main chain amides of the Gly-Leu-Gly-Phe motif form hydrogen bonds
with the terminal carboxylate group (12). The side chain of the
C-terminal residue (position 0) projects into a hydrophobic pocket
accounting for PDZ domains binding preferentially to sequences ending
with a hydrophobic residue (such as valine, isoleucine, or leucine
(23)).
In the crystal structure of PSD-95 PDZ3 with its peptide ligand, the
side chain of the residue at position
1 points away from the
interaction surface (12). This correlates with the relative lack of PDZ
specificity for recognition at the
1 position. Nevertheless,
substitutions at this site can affect binding preference for individual
PDZ domains, albeit to a lesser degree than the 0 and
2 positions
(23-25). In contrast, the guanido group of arginine at position
1 of
the cystic fibrosis transmembrane regulator (CFTR) C terminus
(C-terminal sequence -DTRL) forms two salt bridges and two
hydrogen bonds with residues in PDZ1 of NHERF, indicating that in some
cases the
1 residue contributes directly to the specificity and
affinity of the interaction (19). The crystal structure of the InaD
PDZ1 with a C-terminal peptide from NorpA (C-terminal sequence
-EFCA) further demonstrates a critical role for a cysteine
residue at position
1, as intermolecular disulfide bond formation of
this residue with a cysteine residue in the PDZ domain is required for
high affinity interaction (20).
The binding specificity of PDZ domains is critically determined by the
interaction of the first residue of helix
B (position
B1) and the
side chain of the
2 residue of the C-terminal ligand; this forms the
basis for PDZ classification (Table I)
(23). In Class I PDZ interactions, such as those of PSD-95, a serine or
threonine residue occupies the
2 position. The side chain hydroxyl
group forms a hydrogen bond with the N-3 nitrogen of a histidine
residue at position
B1 (12), which is highly conserved among Class I
PDZ domains. In contrast, class II PDZ interactions are characterized
by hydrophobic residues at both the
2 position of the peptide ligand
and the
B1 position of the PDZ domain (23). A third class of PDZ
domains, such as nNOS, prefers negatively charged amino acids at the
2 position (24). This specificity is determined by the coordination
of the hydroxyl group of a tyrosine residue at position
B1 with the
side chain carboxylate of the
2 residue (24, 26). Other classes of
PDZ domain specificities are likely to be distinguished with further
research.
|
PDZ domains vary in their range and stringency of specificity. For
example, the PDZ domain of PICK1, which has a lysine residue at the
B1 position, can bind the C termini of both protein kinase C (ending
in -QSAV (27)) and the AMPA receptor subunit GluR2 (ending in -SVKI
(28)). Thus, a single PDZ domain can show both Class I and Class II
specificity; the three-dimensional structural basis of this promiscuity
remains to be determined.
Whereas the residue at the
2 position is a key determinant of
PDZ-ligand interactions, more N-terminal residues in PDZ-binding peptides also contribute to specificity. Crystallographic data indicate
that the
3 side chain also directly contacts the peptide-binding groove (12, 19, 26), and the residue at position
3 is important in
determining the binding of ligands selected from a peptide library
(23). Moreover, several studies have demonstrated that residues beyond
the last four amino acids are also important, up to position
8 (18,
23, 25).
Although many examples of PDZ-peptide ligand interactions have now been
identified, uncertainty remains regarding the binding affinity of the
PDZ domain for its ligand. Using solid phase methods such as surface
plasmon resonance (Biacore) or modified enzyme-linked immunosorbent
assays, affinities of PDZ binding to their cognate peptides have been
measured in the 10-100 nM range. On the other hand,
solution methods such as fluorescence polarization suggest that the
binding affinity may be weaker in the low micromolar range (25, 29). It
is likely that a wide range of affinities applies to the diversity of
PDZ domain interactions in vivo. Moreover, especially
because many PDZ ligands are membrane-associated and clustered, it is
difficult to know whether solid phase or solution methods better
approach the in vivo situation.
| |
Regulation of PDZ Binding to C-terminal Sequences |
|---|
|
|
|---|
The regulation of protein-protein interactions between modular
elements such as SH3 domains and their binding partners is often
critical for cell signaling (30). What regulates the binding of PDZ
domains to their respective C-terminal ligands? One mode of control is
the phosphorylation of residues within the C-terminal sequences that
bind the PDZ domain. For example, serine phosphorylation at position
2 in the inward rectifier K+ channel Kir2.3 by protein
kinase A disrupts binding to the PDZ domains of PSD-95 (31). The
association of
2-adrenergic receptor with NHERF is
similarly abolished by phosphorylation at position
2 by
G-protein-coupled receptor kinase GRK5 (32). Intriguingly, binding of a
single C-terminal peptide ligand to multiple PDZ domains can be
differentially regulated. For instance, phosphorylation at serine 880 of the AMPA receptor subunit GluR2 (C-terminal sequence -SVKI) by protein kinase C inhibits binding to the PDZ domain of
GRIP1 but not to PICK1 (33, 34). PDZ interactions may also be regulated
by extracellular signals, as the binding of the
2-adrenergic receptor C terminus to NHERF is stimulated
by
-adrenergic agonists (35). Thus, it is likely that both
intracellular and extracellular signals regulate the temporal and
spatial organization of PDZ-based interactions.
| |
Binding of PDZ Domains to Internal Sequences |
|---|
|
|
|---|
Although binding to C-terminal peptides appears to be the typical
mode of interaction, PDZ domains can also interact with internal
peptide sequences. The best example of this is the interaction of nNOS
with the PDZ domain of PSD-95 or syntrophin (36, 37). In the crystal
structure of the nNOS-syntrophin PDZ complex, amino acid residues
adjacent to the canonical PDZ domain of nNOS form a two-stranded
-hairpin "finger," which docks in the peptide-binding groove of
the syntrophin PDZ domain (Fig. 1B) (14, 26). The sharp
turn of the
-finger binds to the same site as the terminal carboxylate group of peptide ligands (36). Introduction of point mutations that destabilize the nNOS
-finger conformation results in
decreased binding to the syntrophin PDZ domain, supporting the model
that the
-finger is required for proper recognition (29). Screening
of combinatorial phage libraries has also identified cyclic peptides as
potential ligands for PDZ domains; PDZ binding of these peptides
depends on intramolecular disulfide bond formation (38). These examples
suggest that PDZ domains may interact with internal sequences that are
conformationally constrained, structurally mimicking a free C terminus.
In addition, PDZ domains can associate with other PDZ domains to form
homo- and hetero-oligomers. Examples include GRIP (39, 40), ZO-1 (41),
InaD (42), and NHERF (43, 44). PDZ domains are also reported to
interact with other distinct protein-binding motifs, including ankyrin
repeats (45), spectrin repeats (46), and LIM domains (47). The
structural bases for these interactions are not yet clear.
| |
Structural Features of PDZ-containing Proteins |
|---|
|
|
|---|
A fascinating feature of PDZ-containing proteins is that they
often contain multiple PDZ domains (up to 13 in the MUPP1 protein (48))
(Fig. 2). In many cases, the PDZ domains
are closely grouped into tandem arrays, including pairs
(e.g. PDZ1,2 of PSD-95) and triplets (e.g.
PDZ1-3 and PDZ4-6 of GRIP). The significance of PDZ grouping is not
known. However, there is some evidence to suggest that multiple domains
can cooperate to enhance binding to target ligands. For instance,
syntenin contains two PDZ domains in tandem. PDZ2 of syntenin binds to
the C terminus of syndecan, neurexin, and ephrin-B1 only when paired
with PDZ1 (or another copy of PDZ2) but does not interact when
presented in isolation (49). In addition, a recent report suggests that
one PDZ domain may influence the folding of an adjacent PDZ domain
(50). In this example, PDZ5 of GRIP alone was unstructured in solution by nuclear magnetic resonance and circular dichroism spectroscopy and
failed to bind GluR2. However, when covalently connected to PDZ4, PDZ5
became highly structured and GluR2 binding was restored.
|
PDZ domains are also often found in proteins with other known
interaction domains or signaling domains (Fig. 2). The superfamily of
proteins called membrane-associated guanylate kinases (MAGUKs), which
includes PSD-95/SAP90, Dlg, and ZO-1, is characterized by one or more
PDZ domains, an SH3 domain, and a catalytically inactive guanylate
kinase-like domain. PDZ domains also occur in proteins with WW, LIM,
and calcium/calmodulin-dependent protein kinase-like domains as well as ankyrin and leucine-rich repeats. Recently a
cytoplasmic protein, PDZ-RGS3, was identified that binds B-ephrins through its PDZ domain and has a regulator of heterotrimeric G protein
signaling (RGS) domain (51).
| |
PDZ Domains as Organizers of Protein Complexes |
|---|
|
|
|---|
The multidomain structure of PDZ-containing proteins enables them to interact with multiple binding partners simultaneously, thereby assembling larger protein complexes (recently reviewed in Refs. 52 and 53). PDZ-based complexes are often localized to specific subcellular compartments. PDZ-based scaffolds have been shown to organize signal transduction pathways such as phototransduction in Drosophila, where ion channels and signaling molecules are co-assembled by the multi-PDZ protein InaD (54-57). MAGUKs appear to play a similar role in the postsynaptic density, a specialized structure at excitatory synapses enriched in glutamate receptors and associated signaling proteins (58-60). In both the examples of InaD and MAGUKs, the ability of PDZ-containing proteins to interact with multiple binding partners creates a protein complex specialized for local signaling functions.
PDZ proteins have also been implicated in the establishment of cell polarity. In Drosophila, two PDZ-containing proteins, Bazooka and PAR-6, form a ternary complex with atypical protein kinase C that is required for proper establishment and maintenance of apical-basal polarity in epithelial tissues (reviewed in Ref. 61). The orthologues of these binding partners in C. elegans are likewise necessary for polarization of the one-cell embryo. Importantly, depletion of any one of the proteins results in mislocalization of the other two, underscoring the functional importance of the complex. The LIN-2·LIN-7·LIN-10 tripartite complex also demonstrates a role for PDZ proteins in protein sorting (62, 63). This complex specifies the basolateral targeting of the epidermal growth factor receptor homolog LET-23 in C. elegans, and the mammalian homologs have been proposed to play a role in NMDA receptor trafficking through an interaction with the kinesin superfamily motor protein KIF17 (64).
These examples and others illustrate the role of PDZ-containing
proteins in determining the subcellular location of their binding
partners. Two recent studies also indicate that PDZ domains can
modulate the function of their associated proteins as well as the
localization, as interaction of the CFTR with either the multi-PDZ
adaptor protein CAP70 or NHERF increases chloride channel activity of
the CFTR protein, perhaps by promoting multimerization of the channel
protein (65, 66). Thus PDZ domains may have a functional role in
modulating the activity of their target ion channels and membrane
receptors (67).
| |
Conclusions |
|---|
|
|
|---|
It is now clear that PDZ domain proteins play an important role in
the targeting of proteins to specific membrane compartments and their
assembly into supramolecular complexes. There is also evidence that
they can regulate the function of their ligands in addition to serving
as scaffolds. Their ability to bind short extreme C-terminal sequences
offers a facile way for PDZ proteins to interact with target proteins
without disrupting the overall structure and function of their ligands.
Key questions remain in understanding how PDZ domains serve their
function. For example, most PDZ domains seem to bind multiple ligands.
What determines the interaction with specific binding partners and how
is this regulated spatially and temporally in the cell? How is ligand binding and protein stoichiometry affected by PDZ-based homo- and
heteromultimerization, and what is the structural basis for multimer
formation? What role does the tandem organization of PDZ domains play
in determining scaffolding function? The answers to these questions and
others await investigation in this exciting and evolving field.
| |
FOOTNOTES |
|---|
* This minireview will be reprinted in the 2002 Minireview Compendium, which will be available in December, 2002.
¶ To whom correspondence should be addressed. E-mail: msheng@mit.edu.
Published, JBC Papers in Press, December 10, 2001, DOI 10.1074/jbc.R100065200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
PDZ, PSD-95/Dlg/ZO-1
homology;
PSD, postsynaptic density;
SAP, synapse-associated protein;
NMDA, N-methyl-D-aspartate;
NHERF, Na+/H+ exchange regulatory factor;
SH2, Src
homology 2;
SH3, Src homology 3;
nNOS, neuronal nitric-oxide synthase;
CFTR, cystic fibrosis transmembrane regulator;
PICK1, protein
interacting with C-kinase 1;
AMPA,
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid;
GRIP, glutamate
receptor-interacting protein;
InaD, inactivation-no afterpotential D;
MUPP1, multi-PDZ containing protein 1;
MAGUK, membrane-associated
guanylate kinase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ponting, C. P. (1997) Protein Sci. 6, 464-468[Abstract] |
| 2. |
Schultz, J.,
Copley, R. R.,
Doerks, T.,
Ponting, C. P.,
and Bork, P.
(2000)
Nucleic Acids Res.
28,
231-234 |
| 3. | Verpy, E., Leibovici, M., Zwaenepoel, I., Liu, X. Z., Gal, A., Salem, N., Mansour, A., Blanchard, S., Kobayashi, I., Keats, B. J., Slim, R., and Petit, C. (2000) Nat. Genet. 26, 51-55[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Bitner-Glindzicz, M., Lindley, K. J., Rutland, P., Blaydon, D., Smith, V. V., Milla, P. J., Hussain, K., Furth-Lavi, J., Cosgrove, K. E., Shepherd, R. M., Barnes, P. D., O'Brien, R. E., Farndon, P. A., Sowden, J., Liu, X. Z., Scanlan, M. J., Malcolm, S., Dunne, M. J., Aynsley-Green, A., and Glaser, B. (2000) Nat. Genet. 26, 56-60[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Montell, C. J. (2000) Nat. Genet. 26, 6-7[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Boerkoel, C. F., Takashima, H., Stankiewicz, P., Garcia, C. A., Leber, S. M., Rhee-Morris, L., and Lupski, J. R. (2001) Am. J. Hum. Genet. 68, 325-333[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Sherman, D. L., Fabrizi, C., Gillespie, C. S., and Brophy, P. J. (2001) Neuron 30, 677-687[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Kim, E., Niethammer, M., Rothschild, A., Jan, Y. N., and Sheng, M. (1995) Nature 378, 85-88[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Kornau, H.-C.,
Schenker, L. T.,
Kennedy, M. B.,
and Seeburg, P. H.
(1995)
Science
269,
1737-1740 |
| 10. |
Niethammer, M.,
Kim, E.,
and Sheng, M.
(1996)
J. Neurosci.
16,
2157-2163 |
| 11. |
Sato, T.,
Irie, S.,
Kitada, S.,
and Reed, J. C.
(1995)
Science
268,
411-415 |
| 12. | Doyle, D. A., Lee, A., Lewis, J., Kim, E., Sheng, M., and MacKinnon, R. (1996) Cell 85, 1067-1076[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Morais Cabral, J. H., Petosa, C., Sutcliffe, M. J., Raza, S., Byron, O., Poy, F., Marfatia, S. M., Chishti, A. H., and Liddington, R. C. (1996) Nature 382, 649-652[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Tochio, H., Hung, F., Li, M., Bredt, D. S., and Zhang, M. (2000) J. Mol. Biol. 295, 225-237[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Daniels, D. L., Cohen, A. R., Anderson, J. M., and Brunger, A. T. (1998) Nat. Struct. Biol. 5, 317-325[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Schultz, J., Hoffmuller, U., Krause, G., Ashurst, J., Macias, M. J., Schmieder, P., Schneider-Mergener, J., and Oschkinat, H. (1998) Nat. Struct. Biol. 5, 19-24[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Hillier, B. J.,
Christopherson, K. S.,
Prehoda, K. E.,
Bredt, D. S.,
and Lim, W. A.
(1999)
Science
284,
812-815 |
| 18. | Kozlov, G., Gehring, K., and Ekiel, I. (2000) Biochemistry 39, 2572-2580[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Karthikeyan, S.,
Leung, T.,
and Ladias, J. A.
(2001)
J. Biol. Chem.
276,
19683-19686 |
| 20. | Kimple, M. E., Siderovski, D. P., and Sondek, J. (2001) EMBO J. 20, 4414-4422[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Liao, D., Qian, J., Chisholm, D. A., Jordan, D. B., and Diner, B. A. (2000) Nat. Struct. Biol. 7, 749-753[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Beebe, K. D., Shin, J., Peng, J., Chaudhury, C., Khera, J., and Pei, D. (2000) Biochemistry 39, 3149-3155[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Songyang, Z.,
Fanning, A. S., Fu, C., Xu, J.,
Marfatia, S. M.,
Chishti, A. H.,
Crompton, A.,
Chan, A. C.,
Anderson, J. M.,
and Cantley, L. C.
(1997)
Science
275,
73-77 |
| 24. | Stricker, N. L., Christopherson, K. S., Yi, B. A., Schatz, P. J., Raab, R. W., Dawes, G., Bassett, D. E., Bredt, D. S., and Li, M. (1997) Nat. Biotechnol. 15, 336-342[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Niethammer, M., Valtschanoff, J. G., Kapoor, T. M., Allison, D. W., Weinberg, T. M., Craig, A. M., and Sheng, M. (1998) Neuron 20, 693-707[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Tochio, H., Zhang, Q., Mandal, P., Li, M., and Zhang, M. (1999) Nat. Struct. Biol. 6, 417-421[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Staudinger, J., Lu, J.,
and Olson, E. N.
(1997)
J. Biol. Chem.
272,
32019-32024 |
| 28. | Xia, J., Zhang, X., Staudinger, J., and Huganir, R. L. (1999) Neuron 22, 179-187[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Harris, B. Z., Hillier, B. J., and Lim, W. A. (2001) Biochemistry 40, 5921-5930[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Pawson, T.,
and Scott, J. D.
(1997)
Science
278,
2075-2080 |
| 31. | Cohen, N. A., Brenman, J. E., Snyder, S., and Bredt, D. S. (1996) Neuron 17, 759-767[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Cao, T. T., Deacon, H. W., Reczek, D., Bretscher, A., and van Zastrow, M. (1999) Nature 401, 286-290[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Matsuda, S., Mikawa, S., and Hirai, H. (1999) J. Neurochem. 73, 1765-1768[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Chung, H. J.,
Xia, J.,
Scannevin, R. H.,
Zhang, X.,
and Huganir, R. L.
(2000)
J. Neurosci.
20,
7258-7267 |
| 35. | Hall, R. A., Premont, R. T., Chow, C. W., Blitzer, J. T., Pitcher, J. A., Claing, A., Stoffel, R. H., Barak, L. S., Shenolikar, S., Weinman, E. J., Grinstein, S., and Lefkowitz, R. J. (1998) Nature 392, 626-630[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Brenman, J. E., Chao, D. S., Gee, S. H., McGee, A. W., Craven, S. E., Santillano, D. R., Wu, Z., Huang, F., Xia, H., Peters, M. F., Froehner, S. C., and Bredt, D. S. (1996) Cell 84, 757-767[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Brenman, J. E.,
Christopherson, K. S.,
Craven, S. E.,
McGee, A. W.,
and Bredt, D. S.
(1996)
J. Neurosci.
16,
7407-7415 |
| 38. |
Gee, S. H.,
Sekely, S. A.,
Lombardo, C.,
Kurakin, A.,
Froehner, S. C.,
and Kay, B. K.
(1998)
J. Biol. Chem.
273,
21980-21987 |
| 39. |
Dong, H.,
Zhang, P.,
Song, I.,
Petralia, R. S.,
Liao, D.,
and Huganir, R. L.
(1999)
J. Neurosci.
19,
6930-6941 |
| 40. | Srivastava, S., Osten, P., Vilim, F. S., Khatri, L., Inman, G., States, B., Daly, C., DeSouza, S., Abagyan, R., Valtschanoff, J. G., Weinberg, R. J., and Ziff, E. B. (1998) Neuron 21, 581-591[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Fanning, A. S.,
Jameson, B. J.,
Jesaitis, L. A.,
and Anderson, J. M.
(1998)
J. Biol. Chem.
273,
29745-29753 |
| 42. |
Xu, X. Z.,
Choudhury, A., Li, X.,
and Montell, C.
(1998)
J. Cell Biol.
142,
545-555 |
| 43. |
Maudsley, S.,
Zamah, A. M.,
Rahman, N.,
Blitzer, J. T.,
Luttrell, L. M.,
Lefkowitz, R. J.,
and Hall, R. A.
(2000)
Mol. Cell. Biol.
20,
8352-8363 |
| 44. |
Fouassier, L.,
Yun, C. C.,
Fitz, J. G.,
and Doctor, R. B.
(2000)
J. Biol. Chem.
275,
25039-25045 |
| 45. | Maekawa, K., Imagawa, N., Naito, A., Harada, S., Yoshie, O., and Takagi, S. (1999) Biochem. J. 337, 179-184 |
| 46. |
Xia, H.,
Winokur, S. T.,
Kuo, W. L.,
Altherr, M. R.,
and Bredt, D. S.
(1997)
J. Cell Biol.
139,
507-515 |
| 47. |
Cuppen, E.,
Gerrits, H.,
Pepers, B.,
Wieringa, B.,
and Hendriks, W.
(1998)
Mol. Biol. Cell
9,
671-683 |
| 48. | Ullmer, C., Schmuck, K., Figge, A., and Lubbert, H. (1998) FEBS Lett. 424, 63-68[CrossRef][Medline] [Order article via Infotrieve] |
| 49. |
Grootjans, J. J.,
Reekmans, G.,
Ceulemans, H.,
and David, G.
(2000)
J. Biol. Chem.
275,
19933-19941 |
| 50. |
Zhang, Q.,
Fan, J-S.,
and Zhang, M.
(2001)
J. Biol. Chem
276,
43216-43220 |
| 51. | Lu, Q., Sun, E. E., Klein, R. S., and Flanagan, J. G. (2001) Cell 105, 69-79[CrossRef][Medline] [Order article via Infotrieve] |
| 52. | Sheng, M., and Sala, C. (2001) Annu. Rev. Neurosci. 24, 1-29[CrossRef][Medline] [Order article via Infotrieve] |
| 53. |
Harris, B. Z.,
and Lim, W. A.
(2001)
J. Cell Sci.
114,
3219-3231 |
| 54. | Montell, C. (1998) Curr. Opin. Neurobiol. 8, 389-397[CrossRef][Medline] [Order article via Infotrieve] |
| 55. | Montell, C. (1999) Annu. Rev. Cell Dev. Biol. 15, 231-268[CrossRef][Medline] [Order article via Infotrieve] |
| 56. | Scott, K., and Zuker, C. (1998) Curr. Opin. Neurobiol. 8, 383-388[CrossRef][Medline] [Order article via Infotrieve] |
| 57. | Tsunoda, S., and Zuker, C. S. (1999) Cell Calcium 26, 165-171[CrossRef][Medline] [Order article via Infotrieve] |
| 58. | Garner, C. C., Nash, J., and Huganir, R. L. (2000) Trends Cell Biol. 10, 274-280[CrossRef][Medline] [Order article via Infotrieve] |
| 59. | Sheng, M., and Pak, D. T. (2000) Annu. Rev. Physiol. 62, 755-778[CrossRef][Medline] [Order article via Infotrieve] |
| 60. | Scannevin, R. H., and Huganir, R. L. (2000) Nat. Rev. Neurosci. 1, 133-141[CrossRef][Medline] [Order article via Infotrieve] |
| 61. | Ohno, S. (2001) Curr. Opin. Cell Biol. 13, 641-648[CrossRef][Medline] [Order article via Infotrieve] |
| 62. | Kim, S. K. (1997) Curr. Opin. Cell Biol. 9, 853-859[CrossRef][Medline] [Order article via Infotrieve] |
| 63. | Bredt, D. S. (1998) Cell 94, 691-694[CrossRef][Medline] [Order article via Infotrieve] |
| 64. |
Setou, M.,
Nakagawa, T.,
Seog, D. H.,
and Hirokawa, N.
(2000)
Science
288,
1796-1802 |
| 65. | Wang, S., Yue, H., Derin, R. B., Guggino, W. B., and Li, M. (2000) Cell 103, 169-179[CrossRef][Medline] [Order article via Infotrieve] |
| 66. |
Raghuram, V.,
Mak, D. D.,
and Foskett, J. K.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
1300-1305 |
| 67. |
Bezprozvanny, I.,
and Maximov, A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
787-789 |
| 68. |
Irie, M.,
Hata, Y.,
Takeuchi, M.,
Ichtchenko, K.,
Toyoda, A.,
Hirao, K.,
Takai, Y.,
Rosahl, T. W.,
and Sudhof, T. C.
(1997)
Science
277,
1511-1515 |
| 69. |
Gee, S. H.,
Madhavan, R.,
Levinson, S. R.,
Caldwell, J. H.,
Sealock, R.,
and Froehner, S. C.
(1998)
J. Neurosci.
18,
128-137 |
| 70. | Wang, S., Raab, R. W., Schatz, P. J., Guggino, W. B., and Li, M. (1998) FEBS Lett. 427, 103-108[CrossRef][Medline] [Order article via Infotrieve] |
| 71. | Naisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., and Sheng, M. (1999) Neuron 23, 569-582[CrossRef][Medline] [Order article via Infotrieve] |
| 72. | Tu, J. C., Xiao, B., Naisbitt, S., Yuan, J. P., Petralia, R. S., Brakeman, P., Doan, A., Aakalu, V. K., Lanahan, A. A., Sheng, M., and Worley, P. F. (1999) Neuron 23, 583-592[CrossRef][Medline] [Order article via Infotrieve] |
| 73. |
Marfatia, S. M.,
Morais-Cabral, J. H.,
Kim, A. C.,
Byron, O.,
and Chishti, A. H.
(1997)
J. Biol. Chem.
272,
24191-24197 |
| 74. |
Hata, Y.,
Butz, S.,
and Sudhof, T. C.
(1996)
J. Neurosci.
16,
2488-2494 |
| 75. |
Hsueh, Y.-P.,
Yang, F.-C.,
Kharazia, V.,
Naisbitt, S.,
Cohen, A. R.,
Weinberg, R. J.,
and Sheng, M.
(1998)
J. Cell Biol.
142,
139-151 |
| 76. | Torres, R., Firestein, B. L., Dong, H., Staudinger, J., Olson, E. N., Huganir, R. L., Bredt, D. S., Gale, N. W., and Yancopoulos, G. D. (1998) Neuron 21, 1453-1463[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
D. Sarkar, H. Boukerche, Z.-z. Su, and P. B. Fisher mda-9/Syntenin: More than Just a Simple Adapter Protein When It Comes to Cancer Metastasis Cancer Res., May 1, 2008; 68(9): 3087 - 3093. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paris, A. Burlacu, and Y. Durocher Opposing Roles of Syndecan-1 and Syndecan-2 in Polyethyleneimine-mediated Gene Delivery J. Biol. Chem., March 21, 2008; 283(12): 7697 - 7704. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, M. Tuzova, Z.-X. J. Xiao, W. W. Cruikshank, and D. M. Center Pro-IL-16 Recruits Histone Deacetylase 3 to the Skp2 Core Promoter through Interaction with Transcription Factor GABP J. Immunol., January 1, 2008; 180(1): 402 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Sommerville, S. E. Kelemen, and M. V. Autieri Increased Smooth Muscle Cell Activation and Neointima Formation in Response to Injury in AIF-1 Transgenic Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 47 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delhaye, A. Gravot, D. Ayinde, F. Niedergang, M. Alizon, and A. Brelot Identification of a Postendocytic Sorting Sequence in CCR5 Mol. Pharmacol., December 1, 2007; 72(6): 1497 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Topffer, A. Muller-Schiffmann, K. Matentzoglu, M. Scheffner, and G. Steger Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses J. Gen. Virol., November 1, 2007; 88(11): 2956 - 2965. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Wang, L. L. P.J. Ooi, and K. M. Hui Identification and Validation of a Novel Gene Signature Associated with the Recurrence of Human Hepatocellular Carcinoma Clin. Cancer Res., November 1, 2007; 13(21): 6275 - 6283. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Mandell, L. Berglin, E. A. Severson, H. F. Edelhauser, and C. A. Parkos Expression of JAM-A in the Human Corneal Endothelium and Retinal Pigment Epithelium: Localization and Evidence for Role in Barrier Function Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 3928 - 3936. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Donowitz and X. Li Regulatory Binding Partners and Complexes of NHE3 Physiol Rev, July 1, 2007; 87(3): 825 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Auerbach and C. M. Liedtke Role of the scaffold protein RACK1 in apical expression of CFTR Am J Physiol Cell Physiol, July 1, 2007; 293(1): C294 - C304. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Navarro-Lerida, M. Martinez-Moreno, I. Ventoso, A. Alvarez-Barrientos, and I. Rodriguez-Crespo Binding of CAP70 to Inducible Nitric Oxide Synthase and Implications for the Vectorial Release of Nitric Oxide in Polarized Cells Mol. Biol. Cell, July 1, 2007; 18(7): 2768 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, X. Niu, Y. Xu, J. Wu, and Y. Shi Solution structure and backbone dynamics of the AF-6 PDZ domain/Bcr peptide complex Protein Sci., June 1, 2007; 16(6): 1053 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bossard, A. Robay, G. Toumaniantz, S. Dahimene, F. Becq, J. Merot, and C. Gauthier NHE-RF1 protein rescues {Delta}F508-CFTR function Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1085 - L1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Elkins, E. Papagrigoriou, G. Berridge, X. Yang, C. Phillips, C. Gileadi, P. Savitsky, and D. A. Doyle Structure of PICK1 and other PDZ domains obtained with the help of self-binding C-terminal extensions Protein Sci., April 1, 2007; 16(4): 683 - 694. [Abstract] [Full Text] [PDF] |
||||